Advanced company searchLink opens in new window

CS PHARMACEUTICALS LIMITED

Company number 13027523

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
31 Oct 2024 AP01 Appointment of Professor Bruce Robinson as a director on 23 October 2024
15 Oct 2024 CS01 Confirmation statement made on 2 October 2024 with updates
21 Jun 2024 AA Micro company accounts made up to 31 December 2023
29 Apr 2024 SH01 Statement of capital following an allotment of shares on 25 March 2024
  • GBP 17.538165
11 Oct 2023 CS01 Confirmation statement made on 2 October 2023 with updates
05 Jun 2023 AA Micro company accounts made up to 31 December 2022
07 Feb 2023 SH01 Statement of capital following an allotment of shares on 6 February 2023
  • GBP 17.233558
11 Jan 2023 CH01 Director's details changed for Mr Darren Mercer on 11 January 2023
01 Dec 2022 SH01 Statement of capital following an allotment of shares on 30 November 2022
  • GBP 17.156284
30 Nov 2022 SH01 Statement of capital following an allotment of shares on 22 November 2022
  • GBP 16.777496
30 Nov 2022 AP01 Appointment of Mr John Dawson as a director on 1 June 2022
29 Nov 2022 CS01 Confirmation statement made on 17 November 2022 with no updates
29 Nov 2022 AP01 Appointment of Mr Roberto Lee as a director on 1 December 2021
10 Nov 2022 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
29 Apr 2022 AA Micro company accounts made up to 31 December 2021
29 Nov 2021 CS01 Confirmation statement made on 17 November 2021 with updates
24 Nov 2021 SH01 Statement of capital following an allotment of shares on 16 November 2021
  • GBP 15.18236
24 Nov 2021 AP01 Appointment of Professor Andrew Wilks as a director on 22 June 2021
01 Nov 2021 SH01 Statement of capital following an allotment of shares on 17 September 2021
  • GBP 13.757121
27 Oct 2021 AA01 Current accounting period extended from 30 November 2021 to 31 December 2021
29 Jul 2021 AP01 Appointment of Mr David Ian Wilson as a director on 29 July 2021
29 Jul 2021 AD01 Registered office address changed from Little Savernake the Wood End Wallington SM6 0RA England to Level 30, the Leadenhall Building 122 Leadenhall Street London EC3V 4AB on 29 July 2021
24 Jun 2021 SH01 Statement of capital following an allotment of shares on 9 June 2021
  • GBP 13.757121
18 Jun 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • GBP 10.214257
18 Jun 2021 SH01 Statement of capital following an allotment of shares on 15 January 2021
  • GBP 10